Genetic interaction between two influenza A-WS virus mutants. I. Characterization of the mutants.
D000372:Agglutination Tests; D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D002490:Central Nervous System; D002642:Chick Embryo; D002645:Chickens; D006224:Cricetinae; D046508:Culture Techniques; D003588:Cytopathogenic Effect, Viral; D004171:Diploidy; D004912:Erythrocytes / Q000276:immunology; D005347:Fibroblasts; D005827:Genetics, Microbial; D000882:Haplorhini; D006385:Hemagglutination Inhibition Tests; D006389:Hemagglutinins, Viral / Q000378:metabolism; D006358:Hot Temperature; D006801:Humans; D007106:Immune Sera; D007668:Kidney; D008251:Macaca; D051379:Mice; D009154:Mutation; D009975:Orthomyxoviridae / Q000187:drug effects / Q000254:growth & development / Q000276:immunology / Q000472:pathogenicity; D011817:Rabbits; D012756:Sheep; D013045:Species Specificity; D013696:Temperature; D014357:Trypsin; D014774:Virulence
D000998:Antiviral Agents; D006389:Hemagglutinins, Viral; D007106:Immune Sera; D000547:Amantadine; D014357:Trypsin